A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects
Clinical trial NCT06932315 · COMPLETED
Trial details
- NCT number
- NCT06932315
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-23
- Primary completion
- 2025-08-13
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.